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Summary A cisplatin(CDDP)-resistant subline of a human lung cancer cell line, PC-7/CDDP, was 4.7-fold
more resistant to CDDP than the parent line in a colony-forming assay. The sensitivity of this cell line to
anthracyclines, vinca-alkaloid, etoposide, mitomycin C, and bleomycin was similar to that of the parental line,
PC-7. However, PC-7/CDDP exhibited 4-fold higher sensitivity to fluorouracil (FUra). Possible mechanisms
associated with the collateral sensitivity to FUra were studied in PC-7/CDDP cells. The sensitivity of both cell
lines to FUra did not correlate with the effect of FUra on RNA. On the other hand, FUra induced a greater
reduction in dTTP pools and more single strand breaks in PC-7/CDDP than in PC-7 cells. These results
suggest that the pathway for de novo deoxyribonucleotide synthesis may be a target for FUra in PC-7/CDDP
cells. However, inhibition of thymidylate synthase after FUra treatment did not correlate with the DNA-
directed activity of FUra. Based on the above findings, the decreased salvage synthesis of dTTP was
considered a possible mechanism of the greater reduction of dTTP pools in PC-7/CDDP cells. However, the
activity of dThd kinase was the same in both cell lines. In the presence of physiological concentrations of
exogenous dThd in the serum, uptake of dThd was less in PC-7/CDDP cells than that in PC-7 cells. Our data
suggest that FUra-induced cytotoxicity in PC-7/CDDP cells is associated with the inhibition ofdTTP synthesis
and that the decreased uptake of dThd is a possible mechanism of the collateral sensitivity to FUra in
PC-7/CDDP cells.
CDDP is one of the most effective antitumour drugs
available for the clinical treatment of human cancers. How-
ever, tumours become clinically unresponsive to this drug
upon continued treatment. Therefore, it is important to
elucidate the mechanisms or related processes of resistance to
CDDP. We previously established a CDDP-resistant subline,
PC-7/CDDP, from a human lung cancer cell line, PC-7, in
order to elucidate the mechanisms of resistance to CDDP
and to assist in developing strategies to circumvent CDDP
resistance (Hong et al., 1988; Bungo et al., 1990; Fujiwara et
al., 1990). We demonstrated that PC-7/CDDP cells do not
exhibit cross-resistance or collateral sensitivity to adriamycin,
daunomycin, mitomycin C, bleomycin, etoposide, or vin-
desine. In contrast, PC-7/CDDP cells exhibited collateral
sensitivity to FUra (Ohe et al., 1990). Determination of the
mechanisms of such enhanced drug sensitivity may reveal the
factors that contribute to cellular sensitivity to FUra and
their relation to the mechanisms of CDDP resistance.
Therefore, we searched for the possible mechanisms as-
sociated with the collateral sensitivity to FUra in PC-7/
CDDP cells.
The mechanism of action of FUra is complex and cyto-
toxicity appears to depend upon the cell type being studied.
FUra is known to exert its cytotoxic effect by at least two
mechanisms: incorporation of FUra into RNA and inhibition
of thymidylate synthase (TS) (Chabner, 1981; Heidelberger et
al., 1983). FUra is anabolised to the ribonucleotide, FUTP.
FUTP is incorporated into RNA, which may alter RNA
function. FUra is also anabolised to the deoxyribomono-
phosphate, FdUMP. In the presence of methylenetetrahydro-
folate cofactor, FdUMP forms a covalent ternary complex
with TS, inhibiting the de novo synthesis of dTMP. Depletion
of dTMP and then dTTP interferes with DNA synthesis and
induces DNA strand breaks (Pagolotti et al., 1981; Lonn &
Lonn, 1986; Yoshioka et al., 1987). In addition, it has been
shown that FUra can be incorporated into DNA, and this
may also contribute to its cytotoxicity (Major et al., 1982;
Sawyer et al., 1984). Furthermore, FUra can be catabolised
to H2FUra and consequently to FUPA and further to F-,-
Ala.
We previously tried to determine the contribution of TS
inhibition by FUra in PC-7/CDDP cells (Ohe et al., 1990).
However, there was no correlation between the level of TS
inhibition revealed by 3H-FdUMP binding assay and sensi-
tivity to FUra. These data suggest that the factors respon-
sible for TS inhibition do not contribute to the collateral
sensitivity of FUra. Therefore, we have examined the effects
of FUra on RNA and dTTP pools to investigate further the
underlying mechanisms responsible for the collateral sensi-
tivity to FUra in PC-7/CDDP cells.
Materials and methods
Drugs and chemicals
RPMI 1640 medium and PBS were purchased from Nissui
Pharmaceutical Co., Tokyo, Japan. Other agents were
obtained from the following sources: CDDP from Bristol
Myers Squibb Co., Tokyo, Japan; FUra from Kyowa Hakko
Kogyo Co., Ltd, Tokyo; FUrd from Mitsui Pharmaceutical
Inc., Tokyo; [6-3H]-FUra (specific activity, 19.3 Cimmol 1)
and [methyl-'4C]-dThd (specific activity, 60 mCi mmol ')
from Amersham Japan Ltd, Tokyo; [6-'4C]-FUra (specific
activity, 56 mCi mmol 1) from New England Nuclear Corp.,
Boston, MA. All other drugs and chemicals were purchased
from Sigma Chemical Co., St Louis, MO if not otherwise
reported.
Cell lines and culture
Line PC-7 derived from an adenocarcinoma of the lung with
no prior exposure to chemotherapeutic agents was kindly
donated by Professor Y. Hayata of the Tokyo Medical Col-
lege. The CDDP-resistant cell line, PC-7/CDDP, was estab-
lished in our laboratory by exposing parental cells to stepwise
increased concentrations of CDDP and cloned by the
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limiting-dilution technique (Hong et al., 1988; Ohe et al.,
1990). Resistance to CDDP was stable for at least 6 months
in CDDP-free medium. Prior to use for experiments, the cell
lines were propagated by culturing them in RPMI 1640
medium supplemented with 10% heat-inactivated FBS
(Immuno-Biochemical Laboratories, Fujioka, Japan), penicil-
lin (100unitsml-') and streptomycin (100 gmlm'). PC-7
and PC-7/CDDP cells were grown as stationary suspension
cultures. Cell cultures were initiated by seeding the medium
with approximately 5 x 104 cells ml-' and grew exponentially
to at least 8 x 105 cells ml-'. All experiments were performed
with cells in the exponential phase of growth. The PC-7/
CDDP were cultured for more than 2 weeks before analysis
in CDDP-free medium. These cells were found to be free of
mycoplasmal contamination by examination with a Hoeschst
stain kit for detection of Mycoplasma in cell culture (Flow
Laboratories, Inc., McLean, VA).
Colony-forming assay
Colony-forming efficiency was assessed in a double-layer soft
agar system as previously described (Ohe et al., 1989, 1990),
except for the use of the same culture medium in both top
and bottom layers. PC-7 and PC-7/CDDP were plated at a
concentration of 3 x 104 cells/well with various concentra-
tions of FUra. The culture plates were incubated at 37°C in
humidified air with 5% CO2. After continuous exposure to
FUra for 15-20 days, colonies larger than 50[Lm in diameter
were counted with an automatic particle counter (CP-2000,
Shiraimatsu Co., Ltd, Tokyo). All assays were performed in
triplicate. The plating efficiency of cell lines without the drug
was 8-9%. The effect of leucovorin (5-formyl-tetrahydro-
folate) on the cytotoxicity of FUra was determined by the
same procedure as described above, except for the addition
of 1-leucovorin [Lederle (Japan), Ltd, Tokyo]. In the
experiments on the effect of Urd or dThd on FUra cyto-
toxicity, each cell line was cultured for 3 days in RPMI 1640
supplemented with dialysed FBS (Cell Culture Laboratories,
Cleveland, OH) in 6-well culture plates. Cells were then
treated with FUra at various concentrations for 3 h in a CO2
incubator. FUra-treated cells were washed with RPMI 1640
medium and cultured in soft agar with or without various
concentrations of dThd and Urd in RPMI 1640 medium plus
10% dialysed FBS as described above. All drugs were dis-
solved in distilled water and stored at - 20°C. They were
diluted with culture medium just before each experiment.
Cellular accumulation and intracellular metabolism ofFUra
Suspensions of PC-7 and PC-7/CDDP cells (2 x 108 cells in
total, respectively) were adjusted to a density of 3 x 105
cells/ml-' and then incubated at 37°C in a CO2 incubator.
Experiments on total cellular accumulation of FUra and its
incorporation into RNA and DNA were initiated by rapid
addition of a small volume of a solution of 14C-FUra. The
final concentration of '4C-FUra was 10 lM. At the time
indicated, the cell suspension was washed three times with
ice-cold PBS by centrifugation at 250g for 5min, and the
cells were lysed in 10 mM Tris-HCI buffer, pH 8.0, containing
1 mM EDTA and 0.1% SDS. Radioactivity in the cells was
counted with 10 ml of Aquasol II scintillation cocktail (New
England Nuclear) in a liquid scintillation counter LS3801
[Beckman Instruments (Japan), Tokyo]. Aliquots of the
lysates were precipitated with 4% PCA. 14C-FUra incor-
porated into RNA was considered to be originally acid-
precipitable material that was no longer precipitable after
incubation for 20 h in 0.1N KOH at 370C, a condition which
degrades RNA to acid-soluble material. After KOH treat-
ment, the solution was neutralised with 0.1 N HCI and
reprecipitated by addition of ice-cold 4% PCA. After centri-
fugation at 1,600 g for 10 min, the radioactivity of the
supernatant was counted in Aquasol II. To measure the
incorporation of '4C-FUra into DNA, the remaining pre- cipitate was washed twice with ice-cold 4% PCA and boiled
in 4% PCA for 20 min, and radioactivity incorporated in this
fraction was counted. The RNA and DNA content of these
alkali-hydrolysed fractions was determined by UV absorption
with hydrolysates of yeast RNA and calf thymus DNA as
standards (Ogur & Rosen, 1950).
Intracellular metabolism of FUra was determined by the
same initial procedure except for the use of 3H-FUra instead
of '4C-FUra. As FdUMP has been reported to be rapidly
degraded (Evans et al., 1980), we used the method of rapid
cell-separation from the culture medium to prevent the intra-
cellular degradation of FUra metabolites. After incubation
for 30 min, 4 ml of the cell suspension was layered over 1 ml
of oil [1.1:1 mixture of dibutyl phthalate and dioctyl
phthalate oils (Tokyo-Kasei Co., Ltd, Tokyo)] with 100 fil of
4% PCA layered under the oil. The tubes were immediately
centrifuged at 1,600g for 3 min and a portion of the acid
layer was removed and neutralised with 1.5 N KOH and
stored at - 70°C until use. Fifteen microlitres of the neut-
ralised supernatant was spotted on a TLC plate with
unlabelled markers. Cellular fluoronucleotides (FdUMP,
FUMP, FUDP and FUTP) were separated on polyethle-
neimine-cellulose plates (Merck Japan Ltd, Tokyo) by using
2% boric acid: 2M NaCI (70:35) as a developer. Rf values of
reference compounds were as follows: FdUrd and FUrd,
0.84; FUra, 0.75; FdUMP, 0.71; FUMP, 0.55; ureidopro-
ponic acid, 0.88; FUDP, 0.12; FUTP, 0.04. Fluoronucleoside,
base and other degradation products of FUra, were detected
by silica gel 60F254 plates (Merck) with chloroform:
methanol:acetic acid (80:20:5) used as a developer (Tatsumi
et al., 1987). Rf values of reference compounds were as
follows: FUra, 0.62; FdUrd, 0.52; FUrd, 0.33; FdUMP and
FUMP, 0.00; FUPA, 0.43; F-P-Ala, 0.03. Rf values of FUDP
and FUTP were determined by fluorography of metabolites
in cells or liver using E3HANCE spray (New England
Nuclear). Spots of unlabelled markers were then scraped out
and placed in scintillation vials. Radioactivity was eluted
from the solid support by shaking with 4% PCA. Aquasol II
scintillation cocktail was then added to the vials and radio-
activity was measured.
Measurement ofintracellular dTTPpool by HPLC
Intracellular dTTP levels in PC-7 and PC-7/CDDP were
measured by the method ofTanaka et al. (1984). In brief, the
cells (1-2 x 105ml-') in RPMI 1640 medium plus 10% FBS
were incubated in a CO2 incubator with and without FUra.
Six hours after the addition of FUra, 25 ml ofcell suspension
was transferred to a 50 ml tube, 5 ml of ice-cold PBS was
added and then suspension was centrifuged at 250g for
5 min. The cell pellet was washed with 30 ml of ice-cold PBS
by centrifugation as above. The volume of the cell suspension
was adjusted to 200isl by the addition of PBS to the cell
pellet on ice. One hundred and fifty microlitres of the cell
suspension was transferred to a 1.5 ml tube and the cell
suspension remaining in the 50 ml tube was used for protein
assay (BCA protein assay kit, Pierce Chemical Co., Rock-
ford, IL) with bovine serum albumin as standard. Then 7.5 il
of ice-cold 100% TCA was added to the 150f1 cell suspen-
sion. The sample was then vortexed, placed on ice for 10min
and were centrifuged at 17,000g for 20 s. The acid-soluble
extract was neutralised by extraction with two volumes of
0.5 M tri-n-octylamine in trichlorotrifluoroethane. For deox-
yribonucleoside triphosphate determination, ribonucleotides
were destroyed by the action of periodate and methylamine
as follows: After addition of 20IL or 20 mM deoxyguanosine
to 80 jl of neutralised cell extract, 20fs1 of 0.2 M PCA was
added, followed by 30 tLI of 4 M methylamine phosphate,
pH 7.5. After incubation for 30 min at 37°C, 2 tl of 1 M
rhamnose was added to destroy the remaining periodate. A
Partisil-lO SAX anion exchange column (4.6 x 250 mm,
Whatman Inc., Clifton, NJ) was used for HPLC and 0.4 M
ammonium dishydrogenphosphate:acetonitrorile, 10: 1 (v/v),
pH 3.30 was used as elutant with a flow rate of 1.5 ml min-'.
A 100ILI aliquot of the periodate-treated sample was injected
into the column at ambient temperature, and the column
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were identified by their retention times and the concentra-
tions of the compounds were determined by comparison of
peak heights with those of accurately prepared standard
solutions.
Alkaline elution assay
For the determination of the FUra-induced DNA single-
strand breaks, the alkaline elution technique described by
Kohn et al. (1974, 1976) and Bungo et al. (1990) was used.
Before the alkaline elution analysis, cells were radiolabelled
by incubation with [methyl-'4C]-dThd for 24 h. Then they
were centrifuged, washed free of radioactivity in the medium,
and incubated with 100ZlM FUra for 48 h at 37°C. For the
positive control of DNA single-strand breaks, cells not
treated with FUra were irradiated with 5 Gy by '"Co a-
irradiation at a dose rate of 0.36 GY min-'. They were then
diluted in cold PBS and gently deposited onto a 2.0 lim
pore-size, 25 mm diameter polycarbonate filter (Nuclepore
Corp., Pleasanton, CA). The cells were lysed on the filter by
treatment for 1 h with 5 ml of a lysis solution containing 2%
SDS, 25 mM Na2 EDTA, 50 mM Tris, 50 mM glycine, and
0.5 mg of proteinase K per ml, pH 10.0. This lysis solution
was allowed to flow through the filter by gravity, and then
the filter was rinsed three times with 3 ml of 20 mM Na2
EDTA, pH 10.0, to remove most of the cell protein, memb-
rane, and RNA. The remaining DNA (more than 97% of
that applied to the filter) was analysed by elution with
tetrapropylammonium hydroxide (Eastman Kodak Co.,
Rochester, NY)-H4EDTA, pH 12.1, at a constant flow rate
of 0.025 to 0.030 ml min '. Then fractions of the eluate were
collected directly into scintillation vials on the fraction collec-
tor at 45 min intervals for 7.5 h. Aquasol II scintillation
cocktail was then added to the vials and radioactivity was
determined with a liquid scintillation counter.
Cellular uptake ofthymidine in short-time exposure
PC-7 and PC-7/CDDP cells were cultured in RPMI 1640
containing 10% dialysed FBS for 1 week prior to use. Cell
samples (106 cells ml-1) in the above fresh medium were
incubated at various temperatures (10°C, 15°C, 25°C) for
5 min before the uptake study was started. dThd and FUra
uptake was then determined by a modification of the oil-stop
method of Plagemann and Woffendin (1989). Briefly, a re-
action mixture (50 il) containing [methyl-'4C]-dThd or 3H-
FUra (0.5-1.0fiCiml-') was layered over oil with 201tl of
23% sucrose layered under the oil in a microcentrifuge tube
(0.25 ml). The tube was placed in the centrifuge and uptake
was initiated by rapid addition of the cell suspension (150jil)
to the reaction mixture. In experiment with an inhibitor,
dipyridamole (DP) was added to the cell suspension 5 min
before the addition of the suspension to the reaction mixture.
The uptake was terminated by turning the centrifuge on and
pelleting the cells through the oil mixture to the sucrose layer
as described in the procedure for determination of the
metabolism of FUra, except for using 1% SDS for cell lysis.
After the addition of Aquasol II, radioactivity in the cell
pellet was measured by a liquid scintillation counter. The
volume of medium trapped in the cell pellet was determined
by using '4C-inulin (Amersham). The values for PC-7 and
PC-7/CDDP cells were 0.48 ± 0.08yl and 0.42 ± 0.06 ftl,
respectively. Drug uptake data were corrected for the
radioactivity of the trapped medium.
Results
Cellular sensitivity to CDDP and FUra
The PC-7 and PC-7/CDDP cells lines had almost the same
amounts of DNA, RNA, and protein and about the same
cellular volume (PC-7, 1.4 ± 0.7pI; PC-7/CDDP, 1.2 +
0.3 pl) as determined with a Coulter chanelayzer model ZBI
(Coulter Electronics Inc., Hialeah, FL). The cytotoxicity of
CDDP and FUra in these cell lines is shown in Table I.
PC-7/CDDP cells were about 4.7 times as resistant to CDDP
than PC-7 cells in a colony-forming assay. On the other
hand, PC-7/CDDP cells were more sensitive to FUra than
PC-7 cells. The IC50 of FUra in PC-7/CDDP cells (3.6pM)
was about four times lower than that in PC-7 cells (13.1 JAM)
when both cell lines were treated by continuous drug
exposure.
Effect ofUrd, dThd and leucovorin on the cytotoxicity ofFUra
To find out whether FUra acts mainly by inhibiting DNA
synthesis or by alternating RNA function, we studied the
effect of dThd and Urd on FUra cytotoxicity. dThd is
thought to protect against the reduction in dTTP pools and
Urd is thought to prevent the incorporation of FUTP into
RNA. Urd prevented FUra cytotoxicity in PC-7 cells, but
only a little prevention was observed in PC-7/CDDP cells
(Table II). On the other hand, dThd prevented FUra
cytotoxicity in both cell lines. The reversal effect of dThd in
PC-7 cells was observed with low concentrations of dThd
and reached a plateau at 1 JAM. However, a higher concentra-
tion of dThd was necessary for the prevention of FUra-
induced cytotoxicity in PC-7/CDDP cells. We also studied
the effect of leucovorin on the cytotoxicity of FUra by a
colony-forming assay (Figure 1). This reduced folate is
known to enhance the inhibition of TS by FdUMP
(Keyomarsi & Moran, 1986; Park et al., 1988). In our study
leucovorin enhanced the cytotoxicity of FUra in PC-7/CDDP
cells but not in PC-7 cells. These data suggest that FUra acts
mainly deoxyribonucleotide synthesis in PC-7/CDDP cells.
Measurement ofthe intracellular accumulation ofFUra and its
metabolism
We measured the cellular accumulation of FUra and its
incorporation into nucleic acid in each cell lines by using
'4C-FUra. Total accumulation of FUra in PC-7/CDDP cells
was decreased to 10% of that in PC-7 cells (Figure 2a). We
also measured the incorporation of FUra into the RNA
fraction (Figure 2b). The incorporation of FUra into RNA
was parallel with the total cellular accumulation in each cell
line with approximately 50% of the total accumulation of
FUra incorporated into RNA in each case. Corresponding to
the inhibitory effect of Urd on FUra-induced cytotoxicity,
Table I Cytotoxicity ofCDDP and FUra for PC-7 and PC-7/CDDP human lung cancer cell
lines
IC50 (pM)a
Drug Drug exposure PC-7 PC-7/CDDP IC50 ratiob
CDDP Continuous 1.6 ± 0.3c 7.3 ± 3.6d 4.7
FUra 3 h 75.5 ± 7.8 38.0 ± 12.8d 0.50
Continuous 13.1 ± 7.3 3.6 ± 1.8d 0.27
aDrug concentration inhibiting colony formation by 50%. 'ICs ratio equals the IC50 ofthe
resistant cell line divided by the IC50 ofthe parental cell line. cEach value is the mean ± s.d. of
three independent experiments. dp<0.01 compared to the value for PC-7 (unpaired two-tailed
Student's t-test).860 Y. SUGIMOTO et al.
TableII SuppressiveeffectofdThdandUrdonthecytotoxicity ofFUrainPC-7
and PC-7/CDDP cells
Concentration IC,0 ofFUra (jiM)a
Compound (laM) PC-7 PC-7/CDDP
0 75 (L.)b 36 (1.00)
0.1 73 (0.97) 35 (0.97)
Urd 1 74 (0.99) 35 (0.97)
10 154 (2.05) 39 (1.08)
30 320 (4.27) 43 (1.19)
0.1 86 (1.14) 40 (1.11)
dThd 1 127 (1.69) 42 (1.17)
10 145 (1.93) 58 (1.61)
30 125 (1.66) 92 (2.56)
b aDrug concentration that inhibits colony formation by 50%. bNumber in
parentheses is the IC5o ratio which equals the IC50 ofthe cells treated with either
Urd ofdThd divided by the IC5o of the control cells.
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Figure 1 Effect of leucovorin on the cytotoxicity of FUra in
PC-7 and PC-7/CDDP cells. PC-7 and PC-7/CDDP cells were
treated by continuous exposure to various concentrations of
FUra in the presence or absence of 20gLM of leucovorin and then
assayed for colony formation. Values are means ± s.d. for three
determinations. -0- PC-7; FUra. A PC-7; FUra + LV.
-O- PC7/CDDP; FUra. ------A PC-7/CDDP; FUra + LV.
the amount of FUra incorporated into RNA in PC-7/CDDP
cells was 17% of that in PC-7 cells. We also measured the
incorporation of FUra into the DNA fraction, but the
amount incorporated was very small (less than 2% of the
incorporation into the RNA fraction) in PC-7 cells and there
was even less incorporation of radioactivity into DNA in
PC-7/CDDP cells (Figure 2c).
To confirm the results on FUra-incorporation into RNA,
the amounts of intracellular metabolites of FUra were
measured by TLC (Figure 3). Fluororibonucleotide (FUMP,
FUDP, and FUTP) production in PC-7/CDDP cells was
decreased to less than 18% of that in PC-7 cells. Although
we could not separate the FUDP and FUTP in this TLC
method, decreased production of FUTP in PC-7/CDDP cells
was confirmed by a previously described HPLC method
(Pagolotti et al., 1981). FUTP production in PC-7/CDDP
cells was about 30% of that in PC-7 cells (data not shown).
FdUMP, which interacted with TS, was present at higher
level in PC-7/CDDP cells than the fluoro-ribonucleotide,
although the amount of FdUMP in PC-7/CDDP cells was
65% of that in PC-7 cells. There was no enhanced degrada-
a
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Figure 2 Time course study of cellular accumulation of 1"C-
FUra and its incorporation into RNA and DNA of PC-7 and
PC-7/CDDP cells. CDDP-resistant PC-7/CDDP cells and the
parental PC-7 cells in the exponential phase of growth were
incubated with 10 $tM "C-FUra for 6 h at 37C. FUra accumula-
tion and its incorporation into RNA and DNA were determined
as described under Materials and methods. The data shown are
the means and s.d. of triplicate assays. a, FUra accumulation in
whole cells; b, FUra incorporation into RNA; c, FUra incorpora-
tion into DNA. 0, PC-7; *, PC-7/CDDP.
tion of FUra in PC-7/CDDP cells in comparison with that in
PC-7 cells. These data show that the synthesis of fluoro-
rubinucleotides was decreased more than the synthesis of
FdUMP in PC-7/CDDP cells.
Change ofdTTP levels inducedby FUra
Inhibition of TS activity by FdUMP results in a reduction in
dTTP levels (Yoshioka et al., 1987). We did not, however,
find enhanced inhibition of TS activity in PC-7/CDDP cells
in our previous study; the free TS level was almost the same
in both cell lines after 6 h FUra treatment (Ohe et al., 1990).
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Figure 3 TLC analysis of intracellular metabolites of FUra in
acid-soluble fraction. PC-7 and PC-7/CDDP cells were exposed
to 101 M 3H-FUra for 30min. Then the cells were collected by
centrifugation into 4% PCA under an oil layer. After neutralisa-
tion of the PCA, metabolites of FUra were analysed by TLC as
described in Materials and methods. Columns, the means of three
individual determinations; bars, s.d. MM, PC-7; _, PC-7/
CDDP.
In the present study, we measured the reduction in the dTTP
level (Figure 4). FUra produced greater reduction in dTTP
level in CDDP-resistant cells after 6 h FUra treatment. This
result is consistent with the fact that PC-7/CDDP cells
showed collateral sensitivity to FUra.
DNA strand breaks in cells treated with FUra
Several reports have described DNA strand breaks following
a reduction in dTTP level (Yoshioka et al., 1987; Lonn &
Lonn, 1986, 1988). Therefore, we examined both cell lines for
formation of DNA strand breaks by the alkaline elution
techniques. More DNA single-strand breaks were observed in
PC-7/CDDP cells (Figure 5). These data suggest that the
toxicity of FUra for PC-7/CDDP cells may be mainly due to
the inhibition of synthesis of substrate for DNA replication.
The degree of inhibition of TS activity is not correlated with
the degree of reduction in dTTP level (Ohe et al., 1990).
Moreover, PC-7/CDDP cells incorporate much less exo-
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Figure 4 Levels of dTTP in PC-7 and PC-7/CDDP cells after
FUra treatment. PC-7 and PC-7/CDDP cells were treated with
FUra for 6 h at 37°C. After the cells were washed with ice-cold
PBS, their dTTP pools were measured by HPLC as described in
Materials and methods. Columns, means of three individual
determinations; bars, s.d. PC-7; =ZI PC-7/CDDP.
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Figure 5 Alkaline elution patterns for PC-7 and PC-7/CDDP
cells treated with FUra. PC-7 and PC-7/CDDP cells labelled with
'4C-dThd were incubated with 100 tsM FUra for 48 h (A, PC-7;
A, PC-7/CDDP). For comparison, results of experiments in
which cells were irradiated with 0-rays (5 Gy) are shown (0, PC-7;
*, PC-7/CDDP). Control cells, 0, PC-7; *, PC-7/CDDP.
genous 3H-dThd (50 nM) into DNA than PC-7 cells (Ohe et
al., 1990). Based on these data, we speculated that salvage
synthesis of dTMP might be different in these cells, which
could explain the greater reduction in dTTP levels in the
PC-7/CDDP cells.
Short-term uptake ofdThd
Our previous study did not reveal a difference in dThd kinase
activity, which catalyses phosphorylation of dThd (Ohe et al.,
1990). Therefore, we examined the membrane transport of
dThd, the initial process of the dThd salvage pathway.
Figure 6 shows short-term uptake of dThd at 25°C, demon-
strated by the rapid sampling technique. Initial uptake of
dThd by PC-7/CDDP cells was lower than that by PC-7 cells
after treatment with 5 gM dThd (Figure 6a,b). However, the
amount of dThd taken up by PC-7/CDDP cells was close to
that by the parental cells at a high concentration of dThd
(Figure 6b). This phenomenon was consistent with the
concentration-response of dThd-suppression of FUra-induced
cytotoxicity seen in the colony-forming assay. In contrast,
cellular uptake of FUra was at almost the same level in both
cell lines, and the amount of FUra incorporated into the cells
increased depending on the exogenous FUra concentration in
the same manner in both cell lines (Figure 7a,b). Under the
conditions of the colony-forming assay, the concentration of
dThd derived from serum is less than 1 g4M (Nottebrock &
Then, 1977; Schaer et al., 1978; Sobrero & Bertino, 1986).
Therefore, decreased uptake of dThd may be responsible for
the decreased dTTP production in PC-7/CDDP cells. We also
determined the rate of dThd transport. As the process of
dThd transport was very rapid at 25°C, we decreased the
temperature to determine the initial rate of dThd uptake.
Although the initial rate of dThd-uptake by PC-7/CDDP
cells was also lower than that by PC-7 cells at 15C, the
difference in dThd-uptake disappeared with the decrease in
assay temperature (Figure 8a). An inhibitor of facilitated
diffusion of nucleoside, DP inhibited the dThd uptake by
both cell lines to a similar extent (Figure 8b). These data
suggest that the factor associated with temperature-depend-
ent and DP-insensitive transport of dThd may be different in
PC-7/CDDP cells.
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Figure 6 Short-term uptake of dThd in PC-7 and PC-7/CDDP
cells 25°C. To study membrane transport of dThd, uptake of
dThd was measured after short-time exposure to '4C-dThd as
described in Materials and methods. a, Time course study of the
uptake of 5 tLM '4C-dThd. Values are means ± s.d. for three
determinations. b, Concentration-dependent uptake of dThd
within 5 s. The standard deviation of three determinations for
each point was within 5%. a, -0- PC-7; - 0 - PC-7/CDDP. b, 0
PC-7; 0 PC-7/CDDP.
Figure 8 Effect of temperature and dipyridamole on the short-
term uptake of dThd. Short-term uptake of '4C-dThd (1 pM) was
measured at low-temperature a or in the presence of DP b as
described in Materials and methods. a, Short-term uptake of
dThd at 15C and I0'C. b, Short-term uptake of dThd in the
presence or absence of 10 fAM DP at 15°C. The standard deviation
of three determinations for each point was within 10%. a, 0
PC-7: 15°C. * PC-7/CDDP: 15°C. A PC-7: 10'C. A PC-7/
CDDP: 10°C. b, 0 PC-7. 0 PC-7/CDDP. A PC-7: DP. A
PC-7/CDDP: DP.
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Figure 7 Short-term uptake of FUra in PC-7 and PC-7/CDDP
cells at 25°C. To study membrane transport of FUra, uptake of
FUra was measured after short-time exposure to 3H-FUra as
described in Materials and methods. a, Time course study of
uptake of 5 ym 3H-FUra. Values are means ± s.d. for three deter-
minations. b, Concentration-dependent uptake of FUra for 5 s.
The standard deviation of three determinations for each point
was within 5%. a, -0-PC-7; b, -.- PC-7/CDDP. b, 0 PC-7;
PC-7/CDDP.
A CDDP-resistant cell line, PC-7/CDDP showed collateral
sensitivity to FUra. The same phenomenon was also seen in
a CDDP-resistant subline of a human colon carcinoma cell
line, BE cells (Fram et al., 1990). There are no previous
reports of mechanistic analyses of this phenomenon.
Therefore, in the present study, we have investigated the
possible mechanism of collateral sensitivity to FUra in PC-7/
CDDP cells. Analysis of cellular FUra metabolites demon-
strated that ribonucleotide synthesis from FUra (FUMP,
FUDP and FUTP) in PC-7/CDDP cells was decreased to less
than 18% of that in PC-7 cells. The amount of FUra incor-
porated ;nto RNA of PC-7/CDDP cells was also decreased,
to 17% of that in PC-7 cells. Urd prevented the cytotoxicity
of FUra in PC-7 cells, but not in PC-7/CDDP cells. Thus,
the collateral sensitivity of FUra in PC-7/CDDP cells cannot
be explained by the effect of FUra on RNA. On the other
hand, dThd prevented the cytotoxicity of FUra in both cell
lines although there are the possible artefacts of testing TS
inhibitors with reference to dThd protection (Jackman et al.,
1984). FdUMP was present at higher level in PC-7/CDDP
cells than the fluoro-ribonucleotide (Figure 3). These results
suggest that FUra mainly inhibits DNA synthesis in PC-7/
CDDP cells. This conclusion was supported by the fact that
leucovorin enhanced the cytotoxicity of FUra in PC-7/CDDP
cells, but not in PC-7 cells. The decreased effect of FUra on
RNA seem to contradict the enhanced sensitivity to FUra in
PC-7/CDDP cells. However, the mechanism of action of
FUra is very complex and it is still under question whether
damage to DNA or to RNA can induce the greater cytotoxic
effect.
The inhibitory effect of FUra on DNA synthesis has been
hypothesised to result from inhibition of TS by FdUMP
(Chabner, 1981; Heidelberger et al., 1983). However, in our
preliminary study, we did not see any enhancement of TS
inhibition in PC-7/CDDP cells when determined by 3H-
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FdUMP binding assay (Ohe et al., 1990). In the present
study, we examined PC-7 and PC-7/CDDP cells for changes
occurring after inhibition of TS by FdUMP. We found that
FUra induced a greater reduction in dTTP pools and more
single-strand breaks of DNA in PC-7/CDDP cells without
the enhanced incorporation of FUra into DNA. After 6 h
treatment with FUra, free TS was at almost the same level in
PC-7 and PC-7/CDDP cells (Ohe et al., 1990), while FUra
induced greater reduction in the dTTP pool in PC-7/CDDP
cells than in PC-7 cells. The same levels of cellular free TS
could produce the same level of dTMP. Additionally, cellular
dTTP levels in both cell lines were the same in the absence of
FUra (Figure 4). Accordingly, it is difficult to explain that
greater reduction in the dTTP pool in PC-7/CDDP cells by
FdUMP-mediated TS inhibition. It might also be possible to
assume that the duration of TS inhibition was greater in
PC-7/CDDP than in PC-7 cells since an in vivo study sug-
gested the importance of the duration of TS inhibition
(Houghton et al., 1986). However, the greater reduction in
the dTTP pool in PC-7/CDDP cells has already been
observed after 6 h FUra treatment. Therefore, the duration
of TS inhibition may not be an important factor in the
mechanism of collateral sensitivity to FUra in PC-7/CDDP
cells.
Although the total TS content of PC-7/CDDP cells was
70% of that of PC-7 cells, Scanlon and Kashani-Sabet (1988)
reported that a CDDP-resistant ovarian carcinoma cell line,
A2780cP, exhibited a 3-fold increase in mRNA for TS and
dihydrofolate reductase and a 2.5-fold increase in the
activities of both enzymes compared with the parental cells.
These CDDP-resistant A2780cP cells showed cross-resistance
to FUra, FdUrd and methotrexate (Lu et al., 1988, Newman
et al., 1988). Teicher et al. (1986) reported that a CDDP-
resistant head and neck squamous cell carcinoma cell line
(SCC-25/CP) showed cross-resistance to methotrexate, but
not to FUra. In addition, Kikuchi et al. (1988) reported that
a CDDP-resistant cell line, KFr, derived from human serous
cystadenocarcinoma of the ovary, showed no cross-resistance
to FUra. Accordingly, the determinants relating to the sen-
sitivity or resistance to FUra in CDDP-resistant cell lines
might differ with the cell line.
The greater reduction in dTTP pools in PC-7/CDDP cells
suggests the decrease in capacity of dTTP synthesis by a
non-TS mediated process. dTMP can be synthesised from
dThd rather than from dUMP in de novo synthesis. Accord-
ingly, another proposed determinant of dTTP production is
the availability of dThd through the salvage pathway
(Nottebrook & Then, 1977; Howell et al., 1978; Sobrero &
Bertino, 1986). We previously showed that less exogenous
3H-dThd (50 nM) was incorporated into DNA of PC-7/
CDDP cells than into that of PC-7 cells, without a significant
difference in dThd kinase activity (Ohe et al., 1990).
Therefore, we examined the membrane transport of dThd,
the initial process of the dThd salvage pathway. Short-term
uptake of dThd was lower in PC-7/CDDP cells than in PC-7
cells. As shown in Figure 6a, it is clear that uptake of dThd
was decreased in PC-7/CDDP cells. The uptake of dThd for
5 s does not mean the initial rate of dThd uptake because
dThd uptake was saturated within 3 s at 25C. However, it is
possible that the difference in dThd uptake for 5 s was
reflected in the difference in the membrane transport of dThd
since the rate of dThd uptake was low in the second phase as
shown in the time course experiment. A decreased initial
uptake of dThd in the linear phase was also observed in
PC-7/CDDP cells at 15°C. As shown in Figure 6b, the
difference in the dThd uptake between PC-7/CDDP and
PC-7 was greater in the lower exogenous dThd concentra-
tions at 25°C. This phenomenon is consistent with the con-
centration response of dThd suppression of FUra-induced
cytotoxicity seen in the colony-forming assay. Lower concen-
trations of dhd (0.1 and 1 pM) did not modify the FUra-
induced cytotoxicity in PC-7/CDDP cells, and higher concen-
trations (10 and 301LM) were necessary for the modification
of the cytotoxicity (Table II). These data clearly demonstrate
that the rate of dThd uptake at a low concentration (1 !LM or
less) is too low to support DNA replication in the absence of
endogenous dTMP synthesis. Therefore, it is possible that
FUra-induced cytotoxicity in PC-7/CDDP cells is associated
with the inhibition of dTTP synthesis and that the decreased
uptake of dThd is the mechanism of the collateral sensitivity
to FUra in PC-7/CDDP cells.
Two dThd-membrane transport systems have been
identified in mammalian cells (Belt, 1983; Vijayalakshmi &
Belt, 1988; Jarvis, 1989; Plagemann & Woffendin, 1989). One
is a symmetrical, non-concentrative and facilitated diffusion
system with broad substrate specificity which has low affinity
for dThd. The other is a sodium- and energy-dependent and
concentrative transport system which has high affinity for
dThd. It may be that the exogenous dThd passes through the
cell membrane mainly by the high-affinity transporter in our
culture condition. In addition, further analysis of dThd-
membrane transport showed that the difference in the levels
of dThd uptake disappeared at low temperature and an
inhibitor of facilitated diffusion, DP, inhibited dThd uptake
in PC-7/CDDP and PC-7 cells to a similar extent. Another
inhibitor, 6-[(4-nitrobenzyl)thio]-9-p-D-ribofurasylpurine also
inhibited dThd uptake by both cell line (data not shown).
These data suggest that a dThd-transporter sensitive to these
inhibitors exists not only in PC-7 cells but also in PC-7/
CDDP cells. Therefore, we now hypothesise that the
decreased uptake of dThd is related to the difference in the
energy-dependent transport of dThd. However, more detailed
analysis is required to elucidate the mechanisms of the
decreased uptake of dThd in PC-7/CDDP cells.
Recently, there have been many studies that demonstrate a
qualitative inverse relationship between drug sensitivity to
CDDP and total intracellular CDDP concentration in many
CDDP-resistant cell lines, exceptions to which include
A2780cP cells (Richon et al., 1987; Waund, 1987; Andrews et
al., 1988; Hospers et al., 1988; Kraker & Moore, 1988;
Kuppen et al., 1988; Newman et al., 1988; Bungo et al., 1990;
Fujiwara et al., 1990). Interestingly, the accumulation of
CDDP in PC-7/CDDP cells was 30% of that in PC-7 cells
(unpublished data). Although CDDP is believed to enter cells
by passive diffusion, an energy-dependent CDDP accumula-
tion mechanism has been demonstrated (Andrews et al.,
1988). It has also been suggested that alteration in drug
uptake might be one of the simplest and earliest events
leading to CDDP resistance (Richon et al., 1987). These
findings further suggest a possibility that the decreased
uptake of dThd is associated with the decreased uptake of
CDDP in PC-7/CDDP cells. Although the mechanisms
underlying the decreased uptake are still unclear, we
speculate that common changed process(es) exist in CDDP
and dThd uptake. The possibility of such factors related to
uptake of CDDP and dThd warrants further study in order
to clarify the mechanisms of drug resistance.
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